Global Aneurysm Therapy Market Research Report 2025(Status and Outlook)
Description
Report Overview
Aneurysm therapy refers to medical interventions aimed at treating aneurysms—abnormal bulges or weak spots in blood vessel walls that can rupture, leading to life-threatening complications such as hemorrhagic stroke. The market encompasses both surgical and minimally invasive treatments, including traditional clipping, endovascular coiling, flow diverters, and stent-assisted embolization, with advancements in technology driving the adoption of less invasive procedures. Growth in this market is fueled by rising incidences of aneurysms due to aging populations, hypertension, and smoking, alongside increasing awareness and improvements in diagnostic imaging. However, high treatment costs, procedural risks, and regulatory challenges pose constraints. Key players include medical device manufacturers and pharmaceutical companies investing in innovative solutions to improve patient outcomes. The market is segmented by product type, aneurysm location (cerebral, aortic, peripheral), and end-user (hospitals, specialty clinics, ambulatory surgical centers), with North America and Europe leading due to advanced healthcare infrastructure, while Asia-Pacific shows rapid growth potential driven by expanding healthcare access and rising disease prevalence.
The global Aneurysm Therapy market size was estimated at USD 613.12 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.23% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Aneurysm Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Aneurysm Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Aneurysm Therapy market.
Global Aneurysm Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Integra Life Sciences Corporation
Medtronic Plc.
Terumo Corporation (Micro Vention)
MicroPort Medical Company
Sequent MedicalInc.
Codman & Shurtleff
Abbott
Boston Scientific
phenox GmbH
Pulsar VascularInc.
Market Segmentation (by Type)
Drug
Surgery
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Aneurysm Therapy Market
Overview of the regional outlook of the Aneurysm Therapy Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Aneurysm Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Aneurysm Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Aneurysm therapy refers to medical interventions aimed at treating aneurysms—abnormal bulges or weak spots in blood vessel walls that can rupture, leading to life-threatening complications such as hemorrhagic stroke. The market encompasses both surgical and minimally invasive treatments, including traditional clipping, endovascular coiling, flow diverters, and stent-assisted embolization, with advancements in technology driving the adoption of less invasive procedures. Growth in this market is fueled by rising incidences of aneurysms due to aging populations, hypertension, and smoking, alongside increasing awareness and improvements in diagnostic imaging. However, high treatment costs, procedural risks, and regulatory challenges pose constraints. Key players include medical device manufacturers and pharmaceutical companies investing in innovative solutions to improve patient outcomes. The market is segmented by product type, aneurysm location (cerebral, aortic, peripheral), and end-user (hospitals, specialty clinics, ambulatory surgical centers), with North America and Europe leading due to advanced healthcare infrastructure, while Asia-Pacific shows rapid growth potential driven by expanding healthcare access and rising disease prevalence.
The global Aneurysm Therapy market size was estimated at USD 613.12 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.23% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Aneurysm Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Aneurysm Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Aneurysm Therapy market.
Global Aneurysm Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Integra Life Sciences Corporation
Medtronic Plc.
Terumo Corporation (Micro Vention)
MicroPort Medical Company
Sequent MedicalInc.
Codman & Shurtleff
Abbott
Boston Scientific
phenox GmbH
Pulsar VascularInc.
Market Segmentation (by Type)
Drug
Surgery
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Aneurysm Therapy Market
Overview of the regional outlook of the Aneurysm Therapy Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Aneurysm Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Aneurysm Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
139 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Aneurysm Therapy
- 1.2 Key Market Segments
- 1.2.1 Aneurysm Therapy Segment by Type
- 1.2.2 Aneurysm Therapy Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Aneurysm Therapy Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Aneurysm Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Aneurysm Therapy Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Aneurysm Therapy Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Aneurysm Therapy Product Life Cycle
- 3.3 Global Aneurysm Therapy Sales by Manufacturers (2020-2025)
- 3.4 Global Aneurysm Therapy Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Aneurysm Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Aneurysm Therapy Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Aneurysm Therapy Market Competitive Situation and Trends
- 3.8.1 Aneurysm Therapy Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Aneurysm Therapy Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Aneurysm Therapy Industry Chain Analysis
- 4.1 Aneurysm Therapy Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Aneurysm Therapy Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Aneurysm Therapy Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Aneurysm Therapy Market
- 5.7 ESG Ratings of Leading Companies
- 6 Aneurysm Therapy Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Aneurysm Therapy Sales Market Share by Type (2020-2025)
- 6.3 Global Aneurysm Therapy Market Size Market Share by Type (2020-2025)
- 6.4 Global Aneurysm Therapy Price by Type (2020-2025)
- 7 Aneurysm Therapy Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Aneurysm Therapy Market Sales by Application (2020-2025)
- 7.3 Global Aneurysm Therapy Market Size (M USD) by Application (2020-2025)
- 7.4 Global Aneurysm Therapy Sales Growth Rate by Application (2020-2025)
- 8 Aneurysm Therapy Market Sales by Region
- 8.1 Global Aneurysm Therapy Sales by Region
- 8.1.1 Global Aneurysm Therapy Sales by Region
- 8.1.2 Global Aneurysm Therapy Sales Market Share by Region
- 8.2 Global Aneurysm Therapy Market Size by Region
- 8.2.1 Global Aneurysm Therapy Market Size by Region
- 8.2.2 Global Aneurysm Therapy Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Aneurysm Therapy Sales by Country
- 8.3.2 North America Aneurysm Therapy Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Aneurysm Therapy Sales by Country
- 8.4.2 Europe Aneurysm Therapy Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Aneurysm Therapy Sales by Region
- 8.5.2 Asia Pacific Aneurysm Therapy Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Aneurysm Therapy Sales by Country
- 8.6.2 South America Aneurysm Therapy Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Aneurysm Therapy Sales by Region
- 8.7.2 Middle East and Africa Aneurysm Therapy Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Aneurysm Therapy Market Production by Region
- 9.1 Global Production of Aneurysm Therapy by Region(2020-2025)
- 9.2 Global Aneurysm Therapy Revenue Market Share by Region (2020-2025)
- 9.3 Global Aneurysm Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Aneurysm Therapy Production
- 9.4.1 North America Aneurysm Therapy Production Growth Rate (2020-2025)
- 9.4.2 North America Aneurysm Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Aneurysm Therapy Production
- 9.5.1 Europe Aneurysm Therapy Production Growth Rate (2020-2025)
- 9.5.2 Europe Aneurysm Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Aneurysm Therapy Production (2020-2025)
- 9.6.1 Japan Aneurysm Therapy Production Growth Rate (2020-2025)
- 9.6.2 Japan Aneurysm Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Aneurysm Therapy Production (2020-2025)
- 9.7.1 China Aneurysm Therapy Production Growth Rate (2020-2025)
- 9.7.2 China Aneurysm Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Integra Life Sciences Corporation
- 10.1.1 Integra Life Sciences Corporation Basic Information
- 10.1.2 Integra Life Sciences Corporation Aneurysm Therapy Product Overview
- 10.1.3 Integra Life Sciences Corporation Aneurysm Therapy Product Market Performance
- 10.1.4 Integra Life Sciences Corporation Business Overview
- 10.1.5 Integra Life Sciences Corporation SWOT Analysis
- 10.1.6 Integra Life Sciences Corporation Recent Developments
- 10.2 Medtronic Plc.
- 10.2.1 Medtronic Plc. Basic Information
- 10.2.2 Medtronic Plc. Aneurysm Therapy Product Overview
- 10.2.3 Medtronic Plc. Aneurysm Therapy Product Market Performance
- 10.2.4 Medtronic Plc. Business Overview
- 10.2.5 Medtronic Plc. SWOT Analysis
- 10.2.6 Medtronic Plc. Recent Developments
- 10.3 Terumo Corporation (Micro Vention)
- 10.3.1 Terumo Corporation (Micro Vention) Basic Information
- 10.3.2 Terumo Corporation (Micro Vention) Aneurysm Therapy Product Overview
- 10.3.3 Terumo Corporation (Micro Vention) Aneurysm Therapy Product Market Performance
- 10.3.4 Terumo Corporation (Micro Vention) Business Overview
- 10.3.5 Terumo Corporation (Micro Vention) SWOT Analysis
- 10.3.6 Terumo Corporation (Micro Vention) Recent Developments
- 10.4 MicroPort Medical Company
- 10.4.1 MicroPort Medical Company Basic Information
- 10.4.2 MicroPort Medical Company Aneurysm Therapy Product Overview
- 10.4.3 MicroPort Medical Company Aneurysm Therapy Product Market Performance
- 10.4.4 MicroPort Medical Company Business Overview
- 10.4.5 MicroPort Medical Company Recent Developments
- 10.5 Sequent MedicalInc.
- 10.5.1 Sequent MedicalInc. Basic Information
- 10.5.2 Sequent MedicalInc. Aneurysm Therapy Product Overview
- 10.5.3 Sequent MedicalInc. Aneurysm Therapy Product Market Performance
- 10.5.4 Sequent MedicalInc. Business Overview
- 10.5.5 Sequent MedicalInc. Recent Developments
- 10.6 Codman and Shurtleff
- 10.6.1 Codman and Shurtleff Basic Information
- 10.6.2 Codman and Shurtleff Aneurysm Therapy Product Overview
- 10.6.3 Codman and Shurtleff Aneurysm Therapy Product Market Performance
- 10.6.4 Codman and Shurtleff Business Overview
- 10.6.5 Codman and Shurtleff Recent Developments
- 10.7 Abbott
- 10.7.1 Abbott Basic Information
- 10.7.2 Abbott Aneurysm Therapy Product Overview
- 10.7.3 Abbott Aneurysm Therapy Product Market Performance
- 10.7.4 Abbott Business Overview
- 10.7.5 Abbott Recent Developments
- 10.8 Boston Scientific
- 10.8.1 Boston Scientific Basic Information
- 10.8.2 Boston Scientific Aneurysm Therapy Product Overview
- 10.8.3 Boston Scientific Aneurysm Therapy Product Market Performance
- 10.8.4 Boston Scientific Business Overview
- 10.8.5 Boston Scientific Recent Developments
- 10.9 phenox GmbH
- 10.9.1 phenox GmbH Basic Information
- 10.9.2 phenox GmbH Aneurysm Therapy Product Overview
- 10.9.3 phenox GmbH Aneurysm Therapy Product Market Performance
- 10.9.4 phenox GmbH Business Overview
- 10.9.5 phenox GmbH Recent Developments
- 10.10 Pulsar VascularInc.
- 10.10.1 Pulsar VascularInc. Basic Information
- 10.10.2 Pulsar VascularInc. Aneurysm Therapy Product Overview
- 10.10.3 Pulsar VascularInc. Aneurysm Therapy Product Market Performance
- 10.10.4 Pulsar VascularInc. Business Overview
- 10.10.5 Pulsar VascularInc. Recent Developments
- 11 Aneurysm Therapy Market Forecast by Region
- 11.1 Global Aneurysm Therapy Market Size Forecast
- 11.2 Global Aneurysm Therapy Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Aneurysm Therapy Market Size Forecast by Country
- 11.2.3 Asia Pacific Aneurysm Therapy Market Size Forecast by Region
- 11.2.4 South America Aneurysm Therapy Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Aneurysm Therapy by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Aneurysm Therapy Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Aneurysm Therapy by Type (2026-2033)
- 12.1.2 Global Aneurysm Therapy Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Aneurysm Therapy by Type (2026-2033)
- 12.2 Global Aneurysm Therapy Market Forecast by Application (2026-2033)
- 12.2.1 Global Aneurysm Therapy Sales (K Units) Forecast by Application
- 12.2.2 Global Aneurysm Therapy Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
